Trial Profile
A Phase I Open Label, Randomised, Single Dose, 2-Way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Colesevelam (Primary)
- Indications Heart transplant rejection; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa; Liver transplant rejection; Pancreas transplant rejection; Psoriasis; Renal transplant rejection; Rheumatoid arthritis; Transplant rejection; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Genzyme Corporation
- 05 Jul 2008 New trial record.